AG
RLMD icon

AlTi Global’s Relmada Therapeutics RLMD Stock Holding History

AlTi Global’s Portfolio RLMD Stock Details RLMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$223K Hold
31,975
– – ﹤0.01% 406
2025
Q4 		$154K Hold
31,975
– – ﹤0.01% 444
2025
Q3 		$64.3K Hold
31,975
– – ﹤0.01% 429
2025
Q2 		$19.2K Hold
31,975
– – ﹤0.01% 415
2025
Q1 		$8.63K Hold
31,975
– – ﹤0.01% 387
2024
Q4 		$16.6K Hold
31,975
– – ﹤0.01% 411
2024
Q3 		$104K Hold
31,975
– – ﹤0.01% 381
2024
Q2 		$95.9K Hold
31,975
– – ﹤0.01% 376
2024
Q1 		$149K Buy
31,975
+260
+0.8% +$1.25K ﹤0.01% 373
2023
Q4 		$131K Buy
+31,715
New +$93.9K ﹤0.01% 346

Other funds holding RLMD

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
SCM
Squadron Capital Management Westmont, Illinois $250M AUM
SSC
Spruce Street Capital New York $416M AUM
VA
VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
O
OrbiMed New York $4.59B AUM 125.28% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $93.4B AUM 35.1% 1-Year Est. Return
Millennium Management
Millennium Management New York $134B AUM 35.51% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return